|Last Update: 05/17/13 - 4:05 PM EDT|
|YTD Performance: 36.21%|
|Previous Close: $23.62|
|52 Week Range: $11.51 - $25.08|
|Oustanding Shares: 195,838,857|
|Market Cap: 4,625,713,802|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||9||9||9||10|
|Growth Rate (Year over Year)||25.56%||16.85%||22.34%||24.67%|
SEE was upgraded from Neutral to Outperform, Credit Suisse said. $31 price target. Recent meeting with management confirms that the company is on the right track to turning the business around.
Shares of SEE now seen reaching $25, Jefferies said. Estimates also raised on hard stance on pricing and restructuring underway. Buy rating.
SEE was downgraded from Market Perform to Underperform, Wells Fargo said. Company's cash generation is lagging.
SEE was downgraded from Overweight to Neutral, JP Morgan said. Valuation call, based on a $22.50 price target.
SEE was upgraded to Buy from Neutral, Citigroup said. $22 price target. Operational improvement under an aggressive new leadership.
Here’s a prime example of why insider buying shouldn’t be followed blindly.
Let's dive in the filings and see what some of the lesser-known investors are up to.
Shares of SEE initiated at Overweight, JPMorgan said. $19 price target. Cheap on legacy FCF with upside.
Shares of SEE now seen reaching $18, Jefferies said. Estimates also lowered on execution issues. Buy rating.
Shares of SEE now seen reaching $15, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Neutral rating.